Wikidata entity: Q7844989
C₂₄H₂₇NO₅S (P274)
Quantities
| P4250 | defined daily dose | 0.4 |
| P2067 | mass | 441.160994 |
| P790 | approved by | ... | Q204711 (Food and Drug Administration) | Food and Drug Administration |
| P233 | canonical SMILES | String | CC1=C(C(=C2CCC(OC2=C1C)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C)O | ??? |
| P373 | Commons category | String | Troglitazone | ??? |
| P1542 | has effect | ... | Q970208 (liver failure) | liver failure |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q59199015 (group of stereoisomers) | group of stereoisomers |
| P8026 | LiverTox likelihood score | ... | Q83283320 (LiverTox toxicity likelihood category A) | LiverTox toxicity likelihood category A |
| P2175 | medical condition treated | ... | Q32147145 (maturity-onset diabetes of the young type 2) | maturity-onset diabetes of the young type 2 |
| P129 | physically interacts with | ... | Q1084878 (Peroxisome proliferator activated receptor gamma) | Peroxisome proliferator activated receptor gamma |
| P129 | physically interacts with | ... | Q7671479 (Transient receptor potential cation channel subfamily M member 3) | Transient receptor potential cation channel subfamily M member 3 |
| P3489 | pregnancy category | ... | Q28123616 (US pregnancy category B) | US pregnancy category B |
| P279 | subclass of | ... | Q133300652 (glitazone) | glitazone |
| P2868 | subject has role | ... | Q575062 (anti-diabetic medication) | anti-diabetic medication |
| P2868 | subject has role | ... | Q50430523 (cytochrome P-450 CYP3A inducers) | cytochrome P-450 CYP3A inducers |
Why not click here or view trends?
log id: 3160647